Endra Life Sciences Inc Reports Results For The Quarter Ended In December: Earnings Summary

ENDRA Life Sciences

14/03/2023 21:01

* ENDRA Life Sciences Inc  NDRA.OQ  reported a quarterly
adjusted
loss of 96 cents​​ per share for the quarter ended in December.
The mean expectation of two analysts for the quarter was for a
loss of 90 cents per share.
    * Reported revenue was zero​; analysts expected $700.00
thousand. 
    * ENDRA Life Sciences Inc's reported EPS for the quarter was
a
loss of 96 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * ENDRA Life Sciences Inc shares had fallen by 7.9% this
quarter.
    * The company reported a quarterly loss of $3.29 million.
    * Wall Street's median 12-month price target for ENDRA Life
Sciences Inc is $92.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 14 at 09:01 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.90          -0.96          Missed
 Sep. 30 2022      -1.10          -1.00          Beat
 Jun. 30 2022      -1.10          -1.20          Missed
 Mar. 31 2022      -1.50          -1.40          Beat